PAP
HRMY icon

Persistent Asset Partners’s Harmony Biosciences HRMY Stock Holding History

Persistent Asset Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-115
Closed -$143K – 400
2025
Q3 		$143K Buy
+115
New +$3.96K 0.1% 146

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Persistent Asset Partners's HRMY Position: Q2 2026 in Review

Persistent Asset Partners reduced its Harmony Biosciences (HRMY) stake by 71% in Q2 2026, selling an estimated $527K and leaving 6,843 shares worth $249K. The position accounts for 0.07% of the portfolio, ranked #185.

Persistent Asset Partners first reported a position in HRMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $660K in Q1 2026. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Persistent Asset Partners held 6,843 shares of Harmony Biosciences worth $249K as of Q2 2026.
  • Persistent Asset Partners sold 16,705 Harmony Biosciences shares in Q2 2026, an estimated $527K.
  • Harmony Biosciences made up 0.07% of Persistent Asset Partners's portfolio in Q2 2026, its #185 holding.
  • Persistent Asset Partners first reported a position in Harmony Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Persistent Asset Partners's Harmony Biosciences position peaked at $660K in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.